NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

APPY - Aspenbio Pharma Inc

AspenBio Pharma, Inc. (AspenBio) is a biomedical company. AspenBio is developing products that address human diagnostic and animal health therapeutic needs. Its product candidate, AppyScore, is a blood-based diagnostic test that will provide emergency department physicians a tool to aid in the management of patients suspected of having acute appendicitis. The test is focused to pro","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# APPYhart

Aspenbio Pharma Inc News


Colorado stocks: Ciber up almost 6%
Denver Business Journal - May 18, 2012
Wall Street ended the week with most Colorado stocks losing ground, although Ciber Inc. did manage to post a gain of nearly 6 percent.

AspenBio Pharma gets delisting warning from Nasdaq
Denver Business Journal - May 16, 2012
AspenBio Pharma Inc. faces delisting from Nasdaq and must increase the value of shareholder's equity to remain on the stock exchange, it said Wednesday.

AspenBio Pharma, Inc.'s Clinical Study Suggests One-Third Of CT Scans Used To Assess Pediatric And Adolescent Patients At Low Risk For Acute Appendicitis Could Potentially Be Avoided
Reuters Key Development - Apr 18, 2012

AspenBio Pharma, Inc. Reports Interim Data From AppyScore Pilot Study And Outlook for Regulatory Pathway
Reuters Key Development - Oct 19, 2011

AspenBio Pharma, Inc.'s AppyScore Pre-Pivotal Trial Advances With Patient Enrollment Ongoing At Seven Hospitals
Reuters Key Development - Jul 19, 2011

AspenBio Pharma, Inc. Announces Management Change
Reuters Key Development - Oct 12, 2010

Rigrodsky & Long, P.A. Announces Class Action Lawsuit Against AspenBio Pharma, Inc.
Reuters Key Development - Oct 7, 2010

The Law Office of Robbins Umeda LLP Announces Filing Of Class Action Suit Against AspenBio Pharma, Inc.
Reuters Key Development - Oct 7, 2010

The Denver-Based Law Firm Of Dyer & Berens LLP Announces Class Action On Behalf Of AspenBio Pharma, Inc. Investors
Reuters Key Development - Oct 6, 2010

The Rosen Law Firm Announces Investigation Of Shareholder Securities Claims Against AspenBio Pharma, Inc.
Reuters Key Development - Sep 4, 2010

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>